| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.802 | 0.004 | 0.802 | 5 Hydroxytryptamine release stimulant | 0.358 0.054 CID_18427220 0.786 0.004 CID_18763384 | ||
| 0.674 | 0.004 | 0.674 | GABA C receptor rho-3 antagonist | 0.511 0.023 CID_18427220 0.67 0.004 CID_18763384 | ||
| 0.671 | 0.003 | 0.671 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.523 0.024 CID_18427220 0.612 0.006 CID_18763384 | ||
| 0.609 | 0.014 | 0.609 | Aryl hydrocarbon receptor agonist | 0.379 0.041 CID_18763384 | ||
| 0.583 | 0.008 | 0.583 | Calcium channel L-type activator | 0.424 0.066 CID_18427220 0.522 0.02 CID_18763384 | ||
| 0.541 | 0.007 | 0.541 | Peroxidase inhibitor | 0.267 0.044 CID_18427220 0.476 0.012 CID_18763384 | ||
| 0.517 | 0.018 | 0.517 | Interleukin antagonist | 0.411 0.029 CID_18763384 | ||
| 0.526 | 0.051 | 0.663 | Caspase 9 stimulant | 0.446 0.085 CID_18427220 0.663 0.028 CID_18763384 | CID_18763384 | |
| 0.464 | 0.004 | 0.464 | 5 Hydroxytryptamine 1 agonist | 0.381 0.005 CID_18763384 | ||
| 0.479 | 0.032 | 0.479 | Vasodilator, peripheral | 0.233 0.141 CID_18427220 0.267 0.115 CID_18763384 | ||
| 0.439 | 0.013 | 0.468 | Calcium channel activator | 0.389 0.029 CID_18427220 0.468 0.008 CID_18763384 | CID_18763384 | |
| 0.452 | 0.051 | 0.452 | 5 Hydroxytryptamine release inhibitor | 0.322 0.141 CID_18427220 0.345 0.119 CID_18763384 | ||
| 0.409 | 0.016 | 0.409 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.136 0.099 CID_18763384 | ||
| 0.386 | 0.003 | 0.386 | 5 Hydroxytryptamine 3E antagonist | 0.244 0.019 CID_18427220 0.348 0.003 CID_18763384 | ||
| 0.385 | 0.005 | 0.385 | 5 Hydroxytryptamine agonist | 0.206 0.014 CID_18763384 | ||
| 0.394 | 0.016 | 0.394 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.173 0.102 CID_18763384 | ||
| 0.382 | 0.005 | 0.382 | 5 Hydroxytryptamine 1E antagonist | 0.351 0.01 CID_18763384 | ||
| 0.379 | 0.004 | 0.379 | GABA C receptor rho-2 antagonist | 0.244 0.013 CID_18427220 0.379 0.004 CID_18763384 | ||
| 0.415 | 0.045 | 0.415 | Aldehyde oxidase inhibitor | 0.197 0.106 CID_18427220 0.232 0.089 CID_18763384 | ||
| 0.423 | 0.064 | 0.428 | Histamine release inhibitor | 0.428 0.061 CID_18763384 | CID_18763384 | |
| 0.361 | 0.025 | 0.361 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.142 0.12 CID_18763384 | ||
| 0.366 | 0.03 | 0.366 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.188 0.172 CID_18427220 0.286 0.075 CID_18763384 | ||
| 0.364 | 0.03 | 0.364 | Insulysin inhibitor | 0.188 0.176 CID_18427220 0.338 0.039 CID_18763384 | ||
| 0.345 | 0.026 | 0.345 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.205 0.087 CID_18763384 | ||
| 0.336 | 0.02 | 0.336 | Tyrosine 3 hydroxylase inhibitor | 0.316 0.026 CID_18427220 0.301 0.033 CID_18763384 | ||
| 0.324 | 0.019 | 0.324 | Gastrin inhibitor | 0.27 0.057 CID_18763384 | ||
| 0.338 | 0.037 | 0.338 | Pyruvate kinase inhibitor | 0.2 0.081 CID_18763384 | ||
| 0.303 | 0.004 | 0.303 | CF transmembrane conductance regulator agonist | 0.168 0.049 CID_18427220 0.253 0.006 CID_18763384 | ||
| 0.329 | 0.03 | 0.329 | Death-associated protein kinase 3 inhibitor | 0.148 0.126 CID_18763384 | ||
| 0.314 | 0.018 | 0.314 | LIM domain kinase 1 inhibitor | 0.165 0.084 CID_18763384 | ||
| 0.306 | 0.017 | 0.306 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.12 0.084 CID_18763384 | ||
| 0.288 | 0.004 | 0.288 | 5 Hydroxytryptamine 3A agonist | 0.097 0.08 CID_18427220 0.253 0.005 CID_18763384 | ||
| 0.288 | 0.004 | 0.288 | 5 Hydroxytryptamine 1B agonist | 0.154 0.004 CID_18763384 | ||
| 0.296 | 0.012 | 0.296 | Nitric-oxide synthase stimulant | 0.198 0.093 CID_18427220 0.251 0.032 CID_18763384 | ||
| 0.302 | 0.021 | 0.302 | Lipocortins synthesis antagonist | 0.162 0.089 CID_18427220 0.254 0.032 CID_18763384 | ||
| 0.289 | 0.014 | 0.289 | 3C-like protease (Human coronavirus) inhibitor | 0.241 0.032 CID_18763384 | ||
| 0.301 | 0.027 | 0.301 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.305 | 0.042 | 0.305 | 5 Hydroxytryptamine uptake stimulant | 0.255 0.076 CID_18427220 0.288 0.052 CID_18763384 | ||
| 0.27 | 0.011 | 0.27 | Ferrochelatase inhibitor | 0.138 0.043 CID_18427220 0.197 0.023 CID_18763384 | ||
| 0.311 | 0.053 | 0.323 | DNA damaging | 0.323 0.049 CID_18763384 | CID_18763384 | |
| 0.289 | 0.031 | 0.289 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.235 0.086 CID_18427220 0.235 0.086 CID_18763384 | ||
| 0.255 | 0.002 | 0.255 | LIM domain kinase 2 inhibitor | |||
| 0.294 | 0.044 | 0.294 | Psychostimulant | 0.19 0.086 CID_18763384 | ||
| 0.285 | 0.035 | 0.286 | RNA-directed DNA polymerase inhibitor | 0.254 0.047 CID_18427220 0.286 0.035 CID_18763384 | CID_18763384 | |
| 0.25 | 0.004 | 0.255 | GABA C receptor rho-1 antagonist | 0.15 0.021 CID_18427220 0.255 0.004 CID_18763384 | CID_18763384 | |
| 0.259 | 0.013 | 0.259 | Alpha 2b adrenoreceptor antagonist | 0.145 0.041 CID_18763384 | ||
| 0.249 | 0.006 | 0.249 | GABA C receptor antagonist | 0.161 0.025 CID_18427220 0.247 0.007 CID_18763384 | ||
| 0.305 | 0.063 | 0.305 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.245 | 0.004 | 0.245 | Prolactin inhibitor | 0.137 0.028 CID_18427220 0.223 0.005 CID_18763384 | ||
| 0.276 | 0.039 | 0.276 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.235 | 0.009 | 0.235 | Protein kinase C gamma inhibitor | 0.102 0.074 CID_18427220 0.17 0.022 CID_18763384 | ||
| 0.231 | 0.005 | 0.231 | CYP2A6 inhibitor | 0.167 0.012 CID_18763384 | ||
| 0.233 | 0.008 | 0.251 | 5 Hydroxytryptamine 1F antagonist | 0.251 0.008 CID_18763384 | CID_18763384 | |
| 0.271 | 0.047 | 0.271 | Clk dual-specificity kinase inhibitor | |||
| 0.268 | 0.046 | 0.268 | MAP kinase kinase 2 inhibitor | 0.181 0.095 CID_18763384 | ||
| 0.255 | 0.033 | 0.255 | Protein kinase C nu inhibitor | |||
| 0.273 | 0.054 | 0.273 | DNA synthesis inhibitor | 0.199 0.125 CID_18427220 0.266 0.057 CID_18763384 | ||
| 0.228 | 0.01 | 0.236 | Beta glucuronidase inhibitor | 0.236 0.009 CID_18763384 | CID_18763384 | |
| 0.266 | 0.049 | 0.266 | EphB2 antagonist | 0.168 0.112 CID_18763384 | ||
| 0.216 | 0.007 | 0.216 | Protein kinase C delta inhibitor | 0.139 0.027 CID_18763384 | ||
| 0.212 | 0.005 | 0.212 | 5 Hydroxytryptamine 5A antagonist | 0.102 0.015 CID_18763384 | ||
| 0.227 | 0.02 | 0.227 | Death-associated protein kinase 2 inhibitor | 0.179 0.055 CID_18427220 0.177 0.058 CID_18763384 | ||
| 0.212 | 0.006 | 0.212 | 5 Hydroxytryptamine 1D antagonist | 0.13 0.015 CID_18763384 | ||
| 0.208 | 0.005 | 0.208 | Myeloperoxidase inhibitor | 0.165 0.009 CID_18763384 | ||
| 0.206 | 0.005 | 0.206 | 5 Hydroxytryptamine 5 antagonist | 0.096 0.016 CID_18763384 | ||
| 0.203 | 0.005 | 0.203 | Histamine N-methyltransferase inhibitor | 0.109 0.038 CID_18427220 0.166 0.01 CID_18763384 | ||
| 0.21 | 0.016 | 0.21 | GABA receptor agonist | 0.135 0.045 CID_18763384 | ||
| 0.242 | 0.049 | 0.242 | CDC-like kinase 4 inhibitor | |||
| 0.203 | 0.011 | 0.203 | Protein kinase C zeta inhibitor | 0.128 0.028 CID_18763384 | ||
| 0.202 | 0.012 | 0.202 | Porphobilinogen synthase inhibitor | 0.147 0.021 CID_18763384 | ||
| 0.235 | 0.046 | 0.235 | Focal adhesion kinase 2 inhibitor | 0.172 0.098 CID_18763384 | ||
| 0.257 | 0.069 | 0.257 | Dyrk kinase inhibitor | |||
| 0.256 | 0.071 | 0.256 | Superoxide dismutase inhibitor | 0.232 0.087 CID_18763384 | ||
| 0.235 | 0.051 | 0.235 | CDC-like kinase 2 inhibitor | |||
| 0.202 | 0.02 | 0.202 | GABA C receptor agonist | 0.106 0.061 CID_18427220 0.202 0.02 CID_18763384 | ||
| 0.196 | 0.015 | 0.201 | Adenylate kinase inhibitor | 0.136 0.033 CID_18427220 0.201 0.015 CID_18763384 | CID_18763384 | |
| 0.198 | 0.018 | 0.198 | Falcipain 3 inhibitor | 0.169 0.028 CID_18763384 | ||
| 0.188 | 0.009 | 0.188 | 5 Hydroxytryptamine 1B antagonist | 0.117 0.018 CID_18763384 | ||
| 0.217 | 0.039 | 0.217 | Protein kinase (CK1) gamma inhibitor | |||
| 0.196 | 0.02 | 0.196 | Nav1.6 sodium channel blocker | 0.148 0.056 CID_18763384 | ||
| 0.22 | 0.044 | 0.22 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.135 0.088 CID_18763384 | ||
| 0.182 | 0.008 | 0.193 | Phenylalanine 4-hydroxylase inhibitor | 0.193 0.007 CID_18763384 | CID_18763384 | |
| 0.304 | 0.132 | 0.304 | MAP kinase kinase 6 inhibitor | |||
| 0.187 | 0.015 | 0.187 | Gastric antisecretory | 0.088 0.082 CID_18763384 | ||
| 0.185 | 0.013 | 0.185 | Triose-phosphate isomerase inhibitor | 0.089 0.061 CID_18427220 0.17 0.015 CID_18763384 | ||
| 0.203 | 0.031 | 0.203 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.176 | 0.009 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.164 0.019 CID_18427220 0.157 0.028 CID_18763384 | ||
| 0.18 | 0.016 | 0.18 | HIV-1 integrase (Overall Integration) inhibitor | 0.166 0.02 CID_18763384 | ||
| 0.225 | 0.064 | 0.225 | MAP kinase kinase 3 inhibitor | 0.211 0.093 CID_18427220 0.195 0.137 CID_18763384 | ||
| 0.165 | 0.004 | 0.165 | GABA B receptor agonist | 0.134 0.005 CID_18763384 | ||
| 0.166 | 0.005 | 0.166 | Somatostatin agonist | 0.067 0.01 CID_18763384 | ||
| 0.196 | 0.037 | 0.196 | Neurotensin receptor agonist | 0.175 0.055 CID_18763384 | ||
| 0.177 | 0.019 | 0.177 | Photosensitizer | 0.102 0.085 CID_18427220 0.142 0.036 CID_18763384 | ||
| 0.232 | 0.075 | 0.232 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.181 | 0.025 | 0.181 | Adenylate cyclase stimulant | 0.18 0.025 CID_18427220 0.173 0.032 CID_18763384 | ||
| 0.186 | 0.031 | 0.186 | Toll-Like receptor 2 antagonist | 0.165 0.043 CID_18763384 | ||
| 0.209 | 0.055 | 0.209 | Growth factor agonist | 0.197 0.065 CID_18763384 | ||
| 0.191 | 0.037 | 0.191 | Interleukin 1 antagonist | |||
| 0.19 | 0.036 | 0.19 | 5 Hydroxytryptamine antagonist | |||
| 0.216 | 0.062 | 0.216 | Neurotrophic factor enhancer | 0.187 0.091 CID_18427220 0.191 0.086 CID_18763384 | ||
| 0.177 | 0.023 | 0.177 | Alpha 2c adrenoreceptor antagonist | 0.105 0.062 CID_18763384 | ||
| 0.167 | 0.014 | 0.167 | Pim-3 kinase inhibitor | 0.106 0.04 CID_18763384 | ||
| 0.289 | 0.139 | 0.289 | 15-Lipoxygenase inhibitor | |||
| 0.18 | 0.031 | 0.18 | 5 Hydroxytryptamine 2B antagonist | 0.123 0.058 CID_18763384 | ||
| 0.153 | 0.005 | 0.153 | 5 Hydroxytryptamine 2A agonist | 0.117 0.01 CID_18763384 | ||
| 0.167 | 0.021 | 0.167 | TRPA1 agonist | 0.156 0.027 CID_18763384 | ||
| 0.21 | 0.064 | 0.21 | DNA methyltransferase I inhibitor | 0.16 0.094 CID_18763384 | ||
| 0.152 | 0.007 | 0.152 | Glycine receptor antagonist | 0.111 0.024 CID_18427220 0.133 0.012 CID_18763384 | ||
| 0.183 | 0.039 | 0.183 | Alpha-N-acetylglucosaminidase inhibitor | 0.135 0.065 CID_18427220 0.157 0.051 CID_18763384 | ||
| 0.205 | 0.062 | 0.205 | Histone acetyltransferase inhibitor | 0.204 0.064 CID_18763384 | ||
| 0.222 | 0.079 | 0.222 | Cyclic AMP phosphodiesterase inhibitor | 0.184 0.107 CID_18427220 0.153 0.148 CID_18763384 | ||
| 0.169 | 0.026 | 0.169 | Polo-like kinase-4 inhibitor | 0.093 0.085 CID_18763384 | ||
| 0.181 | 0.038 | 0.181 | Toll-Like receptor antagonist | 0.124 0.078 CID_18763384 | ||
| 0.174 | 0.032 | 0.174 | MAP3K9 inhibitor | 0.167 0.039 CID_18427220 0.155 0.053 CID_18763384 | ||
| 0.191 | 0.049 | 0.191 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.161 | 0.02 | 0.161 | Androgen antagonist | 0.083 0.062 CID_18427220 0.136 0.027 CID_18763384 | ||
| 0.212 | 0.071 | 0.212 | DNA methylase inhibitor | 0.169 0.102 CID_18763384 | ||
| 0.172 | 0.032 | 0.172 | Antibacterial (Helicobacter pylori) | 0.14 0.056 CID_18763384 | ||
| 0.152 | 0.013 | 0.152 | Somatostatin 1 agonist | 0.138 0.017 CID_18763384 | ||
| 0.153 | 0.015 | 0.153 | Acetylcholine release stimulant | 0.116 0.056 CID_18763384 | ||
| 0.174 | 0.038 | 0.174 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.138 0.096 CID_18763384 | ||
| 0.141 | 0.005 | 0.141 | 5 Hydroxytryptamine 3 agonist | 0.126 0.008 CID_18763384 | ||
| 0.153 | 0.017 | 0.153 | Rho-associated kinase II inhibitor | |||
| 0.14 | 0.004 | 0.14 | 5 Hydroxytryptamine 7 agonist | 0.084 0.011 CID_18763384 | ||
| 0.159 | 0.024 | 0.159 | 5 Hydroxytryptamine 2C antagonist | 0.105 0.043 CID_18763384 | ||
| 0.139 | 0.005 | 0.139 | Aryl hydrocarbon receptor antagonist | 0.095 0.016 CID_18763384 | ||
| 0.161 | 0.028 | 0.161 | Interleukin 8 antagonist | 0.11 0.077 CID_18427220 0.119 0.063 CID_18763384 | ||
| 0.22 | 0.088 | 0.22 | Neuropeptide Y2 antagonist | |||
| 0.168 | 0.035 | 0.168 | MAP kinase kinase 4 inhibitor | 0.149 0.064 CID_18763384 | ||
| 0.16 | 0.028 | 0.16 | Heat shock protein 70 antagonist | 0.145 0.059 CID_18427220 0.148 0.051 CID_18763384 | ||
| 0.174 | 0.043 | 0.174 | NADPH oxidase inhibitor | 0.12 0.083 CID_18763384 | ||
| 0.136 | 0.005 | 0.136 | Cholecystokinin antagonist | 0.081 0.011 CID_18763384 | ||
| 0.16 | 0.03 | 0.16 | Nav1.4 sodium channel blocker | 0.129 0.045 CID_18763384 | ||
| 0.154 | 0.024 | 0.154 | Protein kinase A inhibitor | |||
| 0.222 | 0.092 | 0.222 | Calpain inhibitor | |||
| 0.133 | 0.005 | 0.133 | Protein kinase C theta inhibitor | 0.081 0.014 CID_18763384 | ||
| 0.183 | 0.055 | 0.183 | ATPase inhibitor | 0.136 0.129 CID_18763384 | ||
| 0.178 | 0.053 | 0.178 | Cyclin-dependent kinase 8 inhibitor | 0.15 0.079 CID_18763384 | ||
| 0.144 | 0.02 | 0.144 | Rho-associated kinase inhibitor | |||
| 0.151 | 0.028 | 0.151 | UDP-glucose 4-epimerase inhibitor | 0.147 0.03 CID_18427220 0.122 0.042 CID_18763384 | ||
| 0.128 | 0.005 | 0.128 | Cholecystokinin A antagonist | 0.075 0.013 CID_18763384 | ||
| 0.147 | 0.025 | 0.147 | Urease inhibitor | 0.111 0.054 CID_18763384 | ||
| 0.174 | 0.052 | 0.174 | CDC-like kinase 1 inhibitor | 0.116 0.099 CID_18763384 | ||
| 0.132 | 0.009 | 0.132 | Phosphodiesterase 4C inhibitor | |||
| 0.179 | 0.058 | 0.179 | Cytidine deaminase inhibitor | 0.112 0.111 CID_18763384 | ||
| 0.13 | 0.009 | 0.13 | 5 Hydroxytryptamine 6 antagonist | 0.067 0.031 CID_18763384 | ||
| 0.145 | 0.024 | 0.145 | DOPA decarboxylase inhibitor | 0.137 0.03 CID_18763384 | ||
| 0.133 | 0.014 | 0.133 | Protein kinase B alpha inhibitor | |||
| 0.137 | 0.018 | 0.137 | GABA A receptor agonist | 0.088 0.05 CID_18763384 | ||
| 0.174 | 0.055 | 0.174 | Cyclin-dependent kinase 3 inhibitor | 0.137 0.132 CID_18427220 0.15 0.096 CID_18763384 | ||
| 0.129 | 0.011 | 0.129 | GABA A receptor antagonist | 0.072 0.025 CID_18763384 | ||
| 0.126 | 0.008 | 0.126 | 5 Hydroxytryptamine 3A antagonist | 0.082 0.029 CID_18763384 | ||
| 0.129 | 0.011 | 0.129 | GABA receptor antagonist | 0.07 0.026 CID_18763384 | ||
| 0.136 | 0.02 | 0.136 | Toll-Like receptor 3 antagonist | 0.105 0.044 CID_18763384 | ||
| 0.121 | 0.005 | 0.121 | Somatostatin 4 agonist | 0.058 0.012 CID_18763384 | ||
| 0.12 | 0.005 | 0.12 | Complement C5a chemotactic receptor antagonist | |||
| 0.134 | 0.019 | 0.134 | Alpha adrenoreceptor agonist | |||
| 0.128 | 0.013 | 0.128 | Benzodiazepine agonist | 0.089 0.032 CID_18427220 0.102 0.024 CID_18763384 | ||
| 0.122 | 0.008 | 0.122 | CC chemokine 5 receptor agonist | 0.105 0.017 CID_18763384 | ||
| 0.208 | 0.094 | 0.208 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.118 | 0.004 | 0.118 | GABA B receptor antagonist | 0.071 0.008 CID_18763384 | ||
| 0.163 | 0.05 | 0.163 | MAP kinase 3 inhibitor | 0.152 0.065 CID_18763384 | ||
| 0.123 | 0.01 | 0.123 | Alpha 2 adrenoreceptor agonist | 0.065 0.037 CID_18763384 | ||
| 0.155 | 0.043 | 0.155 | Cathepsin H inhibitor | 0.103 0.101 CID_18427220 0.114 0.084 CID_18763384 | ||
| 0.132 | 0.02 | 0.132 | Interleukin 12 antagonist | |||
| 0.123 | 0.013 | 0.123 | 5 Hydroxytryptamine 3 antagonist | 0.065 0.031 CID_18763384 | ||
| 0.122 | 0.012 | 0.122 | Protein kinase C eta inhibitor | 0.058 0.035 CID_18763384 | ||
| 0.177 | 0.069 | 0.207 | Growth hormone agonist | 0.146 0.09 CID_18427220 0.207 0.056 CID_18763384 | CID_18763384 | |
| 0.12 | 0.013 | 0.12 | Bombesin 1 receptor agonist | 0.112 0.014 CID_18763384 | ||
| 0.126 | 0.019 | 0.126 | Bromodomain-containing protein 2 inhibitor | 0.079 0.078 CID_18763384 | ||
| 0.177 | 0.071 | 0.177 | Succinate dehydrogenase inhibitor | 0.142 0.128 CID_18427220 0.176 0.072 CID_18763384 | ||
| 0.109 | 0.005 | 0.109 | Glutamate (mGluR1a) antagonist | 0.096 0.005 CID_18763384 | ||
| 0.16 | 0.056 | 0.16 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.161 | 0.056 | 0.179 | Toll-Like receptor 9 antagonist | 0.179 0.046 CID_18763384 | CID_18763384 | |
| 0.135 | 0.031 | 0.135 | Creatine kinase inhibitor | 0.103 0.056 CID_18763384 | ||
| 0.112 | 0.008 | 0.112 | Progesterone antagonist | 0.065 0.013 CID_18427220 0.093 0.009 CID_18763384 | ||
| 0.161 | 0.059 | 0.161 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.137 | 0.035 | 0.137 | Mediator release inhibitor | 0.087 0.084 CID_18763384 | ||
| 0.123 | 0.021 | 0.123 | Alpha 2d adrenoreceptor antagonist | 0.104 0.042 CID_18763384 | ||
| 0.118 | 0.016 | 0.118 | Protein kinase C alpha inhibitor | |||
| 0.134 | 0.032 | 0.195 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.133 0.033 CID_18427220 0.195 0.017 CID_18763384 | CID_18763384 | |
| 0.162 | 0.062 | 0.162 | Heat shock protein 90 antagonist | |||
| 0.116 | 0.017 | 0.116 | CDC7 inhibitor | 0.071 0.043 CID_18763384 | ||
| 0.147 | 0.049 | 0.147 | Aldehyde dehydrogenase inhibitor | 0.102 0.095 CID_18763384 | ||
| 0.106 | 0.008 | 0.106 | 5 Hydroxytryptamine 2 agonist | 0.057 0.029 CID_18763384 | ||
| 0.132 | 0.035 | 0.132 | Pim-1 kinase inhibitor | |||
| 0.185 | 0.089 | 0.185 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.152 | 0.056 | 0.152 | Nav1.2 sodium channel blocker | |||
| 0.158 | 0.063 | 0.158 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.102 | 0.007 | 0.102 | Cyclin D1 inhibitor | 0.081 0.017 CID_18763384 | ||
| 0.121 | 0.028 | 0.121 | Phosphodiesterase 4D inhibitor | |||
| 0.18 | 0.089 | 0.18 | I kappa B kinase epsilon inhibitor | 0.156 0.113 CID_18763384 | ||
| 0.182 | 0.091 | 0.191 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.191 0.08 CID_18427220 | CID_18427220 | |
| 0.138 | 0.047 | 0.138 | Cyclin-dependent kinase 5 inhibitor | |||
| 0.113 | 0.023 | 0.113 | Phosphodiesterase 11A inhibitor | |||
| 0.113 | 0.023 | 0.113 | Phosphodiesterase XI inhibitor | |||
| 0.231 | 0.141 | 0.264 | Transcription factor NF kappa B inhibitor | 0.264 0.117 CID_18763384 | CID_18763384 | |
| 0.124 | 0.035 | 0.124 | Nitric-oxide synthase inhibitor | 0.113 0.043 CID_18763384 | ||
| 0.111 | 0.023 | 0.111 | Granulocyte macrophage colony stimulating factor agonist | 0.089 0.053 CID_18427220 0.102 0.033 CID_18763384 | ||
| 0.129 | 0.042 | 0.129 | AMP-activated protein kinase stimulant | |||
| 0.138 | 0.051 | 0.138 | MAP kinase 12 inhibitor | |||
| 0.117 | 0.03 | 0.117 | Alpha 1b adrenoreceptor antagonist | |||
| 0.11 | 0.023 | 0.11 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.1 | 0.014 | 0.1 | Protein kinase C beta inhibitor | 0.064 0.06 CID_18427220 0.08 0.03 CID_18763384 | ||
| 0.162 | 0.076 | 0.162 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.284 | 0.198 | 0.284 | MAP kinase 1 inhibitor | |||
| 0.117 | 0.031 | 0.117 | 5 Hydroxytryptamine 1 antagonist | 0.071 0.053 CID_18763384 | ||
| 0.132 | 0.046 | 0.132 | MAP kinase 13 inhibitor | |||
| 0.135 | 0.051 | 0.135 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.097 | 0.013 | 0.111 | Nicotinic receptor alpha7 subunit antagonist | 0.111 0.01 CID_18763384 | CID_18763384 | |
| 0.128 | 0.045 | 0.128 | Nav1.5 sodium channel blocker | |||
| 0.089 | 0.005 | 0.089 | Adenylate cyclase 1 inhibitor | 0.052 0.024 CID_18427220 0.075 0.01 CID_18763384 | ||
| 0.156 | 0.073 | 0.156 | Melanin inhibitor | 0.156 0.073 CID_18763384 | ||
| 0.137 | 0.054 | 0.137 | Adenylate cyclase inhibitor | 0.134 0.056 CID_18427220 0.122 0.066 CID_18763384 | ||
| 0.145 | 0.063 | 0.145 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.135 | 0.053 | 0.135 | Beta amyloid protein antagonist | 0.134 0.054 CID_18763384 | ||
| 0.096 | 0.015 | 0.096 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.084 0.019 CID_18427220 0.095 0.015 CID_18763384 | ||
| 0.086 | 0.005 | 0.086 | 5 Hydroxytryptamine 1D agonist | 0.072 0.006 CID_18763384 | ||
| 0.097 | 0.016 | 0.097 | 5 Hydroxytryptamine 1A agonist | 0.052 0.028 CID_18763384 | ||
| 0.09 | 0.009 | 0.09 | Aldosterone antagonist | 0.055 0.023 CID_18763384 | ||
| 0.238 | 0.158 | 0.238 | Calpain 2 inhibitor | |||
| 0.111 | 0.032 | 0.111 | Alpha 2a adrenoreceptor antagonist | |||
| 0.082 | 0.007 | 0.082 | Histamine H2 receptor agonist | 0.067 0.011 CID_18763384 | ||
| 0.079 | 0.004 | 0.079 | Bombesin 1 receptor antagonist | 0.071 0.005 CID_18763384 | ||
| 0.167 | 0.093 | 0.167 | MAP kinase kinase 5 inhibitor | 0.153 0.14 CID_18427220 | ||
| 0.106 | 0.032 | 0.106 | Inducible nitric-oxide synthase inhibitor | 0.1 0.037 CID_18763384 | ||
| 0.101 | 0.027 | 0.101 | D-Ala-D-Ala ligase inhibitor | 0.087 0.049 CID_18763384 | ||
| 0.155 | 0.081 | 0.155 | Heat shock protein 90 alpha antagonist | |||
| 0.122 | 0.049 | 0.122 | MAP kinase kinase kinase inhibitor | |||
| 0.123 | 0.051 | 0.123 | MAO A inhibitor | |||
| 0.092 | 0.02 | 0.092 | Phospholipase D inhibitor | 0.083 0.03 CID_18763384 | ||
| 0.086 | 0.014 | 0.086 | Toll-Like receptor 8 antagonist | |||
| 0.083 | 0.012 | 0.084 | Nicotinic alpha3beta2 receptor antagonist | 0.084 0.012 CID_18763384 | CID_18763384 | |
| 0.078 | 0.007 | 0.078 | 5 Hydroxytryptamine 3B antagonist | 0.068 0.009 CID_18763384 | ||
| 0.141 | 0.071 | 0.153 | Pregnane X receptor agonist | 0.153 0.048 CID_18763384 | CID_18763384 | |
| 0.079 | 0.009 | 0.079 | Somatostatin 1 antagonist | 0.071 0.011 CID_18763384 | ||
| 0.111 | 0.041 | 0.192 | Antineoplastic alkaloid | 0.192 0.016 CID_18763384 | CID_18763384 | |
| 0.091 | 0.022 | 0.091 | Biliverdin reductase inhibitor | 0.077 0.028 CID_18427220 0.073 0.03 CID_18763384 | ||
| 0.091 | 0.022 | 0.091 | MAP kinase kinase 7 inhibitor | 0.083 0.037 CID_18427220 0.088 0.028 CID_18763384 | ||
| 0.107 | 0.038 | 0.116 | NADH dehydrogenase inhibitor | 0.116 0.031 CID_18427220 0.089 0.058 CID_18763384 | CID_18427220 | |
| 0.108 | 0.039 | 0.108 | Phosphodiesterase 6D inhibitor | 0.099 0.053 CID_18427220 0.094 0.065 CID_18763384 | ||
| 0.09 | 0.022 | 0.09 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.083 0.031 CID_18427220 0.086 0.027 CID_18763384 | ||
| 0.085 | 0.018 | 0.085 | Heat shock protein 90 beta antagonist | |||
| 0.111 | 0.044 | 0.111 | Electrolyte absorption antagonist | 0.099 0.059 CID_18763384 | ||
| 0.151 | 0.084 | 0.151 | Sigma receptor agonist | |||
| 0.073 | 0.006 | 0.073 | Alpha 1d adrenoreceptor agonist | 0.051 0.015 CID_18763384 | ||
| 0.114 | 0.049 | 0.114 | Carbonic anhydrase III inhibitor | |||
| 0.14 | 0.076 | 0.14 | Activin receptor-like kinase 2 inhibitor | |||
| 0.192 | 0.128 | 0.235 | Interleukin agonist | 0.183 0.137 CID_18427220 0.235 0.09 CID_18763384 | CID_18763384 | |
| 0.077 | 0.014 | 0.077 | H+/K+-transporting ATPase inhibitor | |||
| 0.077 | 0.014 | 0.077 | Prolactin release inhibitor | 0.077 0.014 CID_18763384 | ||
| 0.118 | 0.055 | 0.118 | Vascular endothelial growth factor 1 antagonist | |||
| 0.117 | 0.054 | 0.117 | Aminopeptidase B inhibitor | 0.089 0.073 CID_18763384 | ||
| 0.096 | 0.034 | 0.096 | Rho-associated kinase I inhibitor | |||
| 0.081 | 0.019 | 0.081 | MDM2 inhibitor | 0.069 0.04 CID_18763384 | ||
| 0.115 | 0.053 | 0.115 | Interleukin 2 antagonist | 0.111 0.062 CID_18763384 | ||
| 0.067 | 0.006 | 0.067 | 5 Hydroxytryptamine 2B agonist | 0.053 0.012 CID_18763384 | ||
| 0.074 | 0.013 | 0.074 | Mineralocorticoid receptor antagonist | 0.074 0.013 CID_18427220 | ||
| 0.107 | 0.046 | 0.107 | Lanosterol 14 alpha demethylase inhibitor | 0.092 0.069 CID_18763384 | ||
| 0.07 | 0.009 | 0.07 | GHS receptor agonist | 0.051 0.02 CID_18763384 | ||
| 0.108 | 0.047 | 0.108 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.09 | 0.029 | 0.098 | Neuronal nicotinic receptor antagonist | 0.098 0.025 CID_18763384 | CID_18763384 | |
| 0.124 | 0.064 | 0.124 | Sphingosine 1-phosphate receptor 4 antagonist | 0.11 0.094 CID_18763384 | ||
| 0.084 | 0.024 | 0.084 | Potassium channel (ATP-sensitive) blocker | 0.064 0.053 CID_18763384 | ||
| 0.064 | 0.004 | 0.064 | 5 Hydroxytryptamine 6 agonist | 0.048 0.005 CID_18763384 | ||
| 0.066 | 0.007 | 0.066 | Cholecystokinin B antagonist | 0.042 0.013 CID_18763384 | ||
| 0.104 | 0.045 | 0.104 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.106 | 0.047 | 0.106 | Alcohol dehydrogenase inhibitor | |||
| 0.08 | 0.021 | 0.08 | Pim-2 kinase inhibitor | 0.05 0.045 CID_18763384 | ||
| 0.07 | 0.011 | 0.07 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 CID_18763384 | ||
| 0.149 | 0.09 | 0.151 | Arachidonic acid antagonist | 0.151 0.087 CID_18427220 | CID_18427220 | |
| 0.094 | 0.036 | 0.109 | Nicotinic alpha4beta2 receptor antagonist | 0.109 0.024 CID_18763384 | CID_18763384 | |
| 0.126 | 0.068 | 0.126 | MAP kinase kinase inhibitor | |||
| 0.094 | 0.036 | 0.094 | Protein kinase B gamma inhibitor | |||
| 0.062 | 0.005 | 0.062 | Melatonin receptor 1A agonist | 0.059 0.005 CID_18763384 | ||
| 0.103 | 0.046 | 0.103 | Alpha 2 adrenoreceptor antagonist | 0.075 0.073 CID_18763384 | ||
| 0.117 | 0.06 | 0.117 | Cystathionine beta-synthase inhibitor | |||
| 0.079 | 0.024 | 0.079 | Beta 3 adrenoreceptor antagonist | 0.069 0.036 CID_18763384 | ||
| 0.064 | 0.008 | 0.064 | Somatostatin 5 agonist | 0.053 0.011 CID_18763384 | ||
| 0.088 | 0.032 | 0.088 | Dopamine agonist | |||
| 0.066 | 0.01 | 0.066 | Somatostatin 2 antagonist | 0.055 0.013 CID_18763384 | ||
| 0.076 | 0.021 | 0.076 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.118 | 0.063 | 0.139 | Microtubule formation inhibitor | 0.139 0.044 CID_18427220 0.138 0.045 CID_18763384 | CID_18427220 | |
| 0.075 | 0.02 | 0.075 | Calcium channel P-type blocker | 0.06 0.057 CID_18763384 | ||
| 0.152 | 0.098 | 0.152 | Tumour necrosis factor antagonist | 0.147 0.105 CID_18763384 | ||
| 0.13 | 0.075 | 0.14 | Amylase inhibitor | 0.138 0.07 CID_18427220 0.14 0.069 CID_18763384 | CID_18763384 | |
| 0.08 | 0.026 | 0.08 | Carbonic anhydrase stimulant | 0.053 0.049 CID_18763384 | ||
| 0.086 | 0.032 | 0.086 | I kappa B kinase 1 inhibitor | |||
| 0.075 | 0.021 | 0.075 | Bombesin 3 receptor antagonist | 0.058 0.035 CID_18763384 | ||
| 0.061 | 0.008 | 0.061 | Histamine H1 receptor agonist | 0.058 0.01 CID_18763384 | ||
| 0.08 | 0.027 | 0.08 | Glutamate (mGluR7) antagonist | 0.062 0.061 CID_18763384 | ||
| 0.096 | 0.042 | 0.101 | Acetylcholine nicotinic antagonist | 0.101 0.039 CID_18763384 | CID_18763384 | |
| 0.094 | 0.041 | 0.094 | Catalase inhibitor | 0.069 0.055 CID_18763384 | ||
| 0.109 | 0.056 | 0.109 | Carbonic anhydrase XV inhibitor | |||
| 0.114 | 0.061 | 0.114 | EphA2 antagonist | |||
| 0.058 | 0.005 | 0.058 | GHS receptor antagonist | 0.039 0.013 CID_18763384 | ||
| 0.081 | 0.03 | 0.081 | Alpha 1d adrenoreceptor antagonist | |||
| 0.088 | 0.036 | 0.088 | 5 Hydroxytryptamine 1A antagonist | 0.057 0.056 CID_18763384 | ||
| 0.132 | 0.08 | 0.132 | Aurora-C kinase inhibitor | |||
| 0.065 | 0.015 | 0.065 | Bombesin antagonist | 0.06 0.018 CID_18763384 | ||
| 0.119 | 0.069 | 0.119 | Alkylator | 0.099 0.089 CID_18763384 | ||
| 0.084 | 0.035 | 0.084 | Phosphodiesterase VI inhibitor | |||
| 0.089 | 0.039 | 0.1 | Keratolytic | 0.1 0.03 CID_18763384 | CID_18763384 | |
| 0.059 | 0.01 | 0.059 | Somatostatin 5 antagonist | 0.046 0.015 CID_18763384 | ||
| 0.069 | 0.02 | 0.069 | Bombesin 2 receptor antagonist | 0.058 0.025 CID_18763384 | ||
| 0.14 | 0.092 | 0.158 | Interferon gamma antagonist | 0.158 0.068 CID_18763384 | CID_18763384 | |
| 0.13 | 0.082 | 0.13 | Death-associated protein kinase 1 inhibitor | |||
| 0.066 | 0.019 | 0.066 | Pregnane X receptor antagonist | |||
| 0.062 | 0.015 | 0.062 | Growth hormone release inhibitor | 0.056 0.018 CID_18763384 | ||
| 0.074 | 0.027 | 0.074 | Androgen agonist | 0.066 0.034 CID_18763384 | ||
| 0.06 | 0.014 | 0.06 | Growth hormone secretagogue receptor antagonist | |||
| 0.215 | 0.168 | 0.24 | Vasodilator, coronary | 0.229 0.155 CID_18427220 0.24 0.144 CID_18763384 | CID_18763384 | |
| 0.086 | 0.04 | 0.086 | Acetylcholine M4 receptor antagonist | 0.072 0.054 CID_18763384 | ||
| 0.073 | 0.027 | 0.073 | Alcohol oxidase inhibitor | 0.058 0.038 CID_18763384 | ||
| 0.13 | 0.085 | 0.13 | Vascular endothelial growth factor 3 antagonist | |||
| 0.084 | 0.04 | 0.084 | Histidine decarboxylase inhibitor | 0.068 0.053 CID_18763384 | ||
| 0.091 | 0.047 | 0.091 | I kappa B kinase inhibitor | |||
| 0.058 | 0.015 | 0.058 | Benzodiazepine antagonist | 0.045 0.04 CID_18763384 | ||
| 0.134 | 0.091 | 0.134 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.107 | 0.064 | 0.107 | CDC-like kinase 3 inhibitor | 0.097 0.087 CID_18763384 | ||
| 0.052 | 0.01 | 0.052 | MAP3K5 inhibitor | |||
| 0.234 | 0.192 | 0.242 | Antibacterial | 0.236 0.19 CID_18427220 0.242 0.184 CID_18763384 | CID_18763384 | |
| 0.05 | 0.009 | 0.05 | Free fatty acid receptor 1 antagonist | |||
| 0.071 | 0.03 | 0.081 | Argininosuccinate synthase inhibitor | 0.081 0.025 CID_18427220 0.054 0.043 CID_18763384 | CID_18427220 | |
| 0.073 | 0.032 | 0.073 | Interferon inducer | |||
| 0.055 | 0.014 | 0.055 | Cholecystokinin B agonist | 0.045 0.019 CID_18763384 | ||
| 0.067 | 0.026 | 0.067 | Protein kinase C epsilon inhibitor | |||
| 0.074 | 0.033 | 0.074 | NMDA receptor glycine site agonist | 0.058 0.048 CID_18427220 | ||
| 0.125 | 0.085 | 0.125 | Ribosomal protein S6 kinase inhibitor | |||
| 0.066 | 0.026 | 0.066 | NMDA 2A receptor antagonist | |||
| 0.066 | 0.026 | 0.066 | Cyclin B2 inhibitor | |||
| 0.085 | 0.045 | 0.085 | Interferon agonist | |||
| 0.079 | 0.04 | 0.079 | Glycine receptor agonist | |||
| 0.116 | 0.078 | 0.116 | Nav1.3 sodium channel blocker | |||
| 0.083 | 0.044 | 0.083 | Viral attachment inhibitor | |||
| 0.046 | 0.008 | 0.046 | Cholecystokinin agonist | |||
| 0.101 | 0.064 | 0.101 | Check point kinase 2 inhibitor | |||
| 0.096 | 0.058 | 0.101 | Bile acid receptor antagonist | 0.101 0.048 CID_18763384 | CID_18763384 | |
| 0.08 | 0.042 | 0.08 | Protein kinase B beta inhibitor | |||
| 0.088 | 0.051 | 0.088 | Factor XII inhibitor | |||
| 0.086 | 0.05 | 0.086 | Adrenaline agonist | |||
| 0.051 | 0.014 | 0.051 | Glucocorticoid antagonist | 0.04 0.019 CID_18763384 | ||
| 0.055 | 0.018 | 0.055 | Geranyltranstransferase inhibitor | |||
| 0.112 | 0.076 | 0.112 | Transcription factor STAT6 inhibitor | 0.112 0.075 CID_18763384 | ||
| 0.195 | 0.158 | 0.195 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.04 | 0.004 | 0.04 | Follicle-stimulating hormone antagonist | 0.029 0.005 CID_18763384 | ||
| 0.069 | 0.033 | 0.069 | Cyclin B1 inhibitor | |||
| 0.065 | 0.03 | 0.077 | Fatty acid synthase inhibitor | 0.077 0.02 CID_18763384 | CID_18763384 | |
| 0.053 | 0.017 | 0.067 | Histone deacetylase 7 inhibitor | 0.067 0.014 CID_18763384 | CID_18763384 | |
| 0.068 | 0.033 | 0.068 | Transcription factor RelA inhibitor | |||
| 0.078 | 0.043 | 0.103 | MAP3K7 inhibitor | 0.103 0.02 CID_18763384 | CID_18763384 | |
| 0.038 | 0.004 | 0.038 | Somatostatin 3 agonist | 0.027 0.005 CID_18763384 | ||
| 0.049 | 0.015 | 0.049 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.083 | 0.049 | 0.083 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.07 | 0.036 | 0.07 | Dopamine D4 antagonist | 0.054 0.046 CID_18763384 | ||
| 0.062 | 0.028 | 0.062 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.05 | 0.016 | 0.05 | Histone deacetylase 9 inhibitor | 0.043 0.022 CID_18763384 | ||
| 0.04 | 0.006 | 0.04 | Thyroid hormone agonist | |||
| 0.063 | 0.029 | 0.063 | Phosphodiesterase II inhibitor | |||
| 0.045 | 0.011 | 0.045 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.043 | 0.01 | 0.043 | ATR kinase inhibitor | |||
| 0.089 | 0.056 | 0.089 | Stem cell growth factor agonist | |||
| 0.059 | 0.027 | 0.059 | Aconitate hydratase inhibitor | 0.058 0.028 CID_18763384 | ||
| 0.076 | 0.044 | 0.076 | Syk tyrosine kinase inhibitor | |||
| 0.095 | 0.063 | 0.095 | MAP kinase kinase 1 inhibitor | |||
| 0.04 | 0.008 | 0.04 | Somatostatin 3 antagonist | 0.03 0.009 CID_18763384 | ||
| 0.066 | 0.034 | 0.066 | Glutamate (mGluR1) antagonist | |||
| 0.086 | 0.054 | 0.086 | mTOR complex 2 inhibitor | |||
| 0.077 | 0.045 | 0.077 | NMDA 2 receptor antagonist | |||
| 0.041 | 0.009 | 0.041 | Nicotinic alpha3beta4 receptor agonist | 0.032 0.018 CID_18763384 | ||
| 0.044 | 0.012 | 0.044 | Prostaglandin EP3 antagonist | |||
| 0.128 | 0.097 | 0.128 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.067 | 0.036 | 0.067 | TRPA1 antagonist | |||
| 0.108 | 0.077 | 0.108 | Proteasome inhibitor | 0.105 0.081 CID_18763384 | ||
| 0.035 | 0.005 | 0.035 | Imidazoline I1 receptor antagonist | 0.022 0.013 CID_18427220 0.022 0.013 CID_18763384 | ||
| 0.07 | 0.04 | 0.078 | Glutamate (mGluR6) antagonist | 0.078 0.027 CID_18763384 | CID_18763384 | |
| 0.083 | 0.053 | 0.083 | Carbonic anhydrase VI inhibitor | |||
| 0.068 | 0.038 | 0.068 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.052 | 0.022 | 0.052 | Potassium channel small-conductance Ca-activated blocker | 0.041 0.038 CID_18763384 | ||
| 0.083 | 0.053 | 0.083 | Acetylcholine nicotinic agonist | |||
| 0.039 | 0.01 | 0.039 | Liver X receptor alpha antagonist | |||
| 0.062 | 0.034 | 0.062 | Alpha 1 adrenoreceptor agonist | |||
| 0.146 | 0.118 | 0.146 | Anesthetic general | |||
| 0.051 | 0.022 | 0.051 | Liver X receptor agonist | |||
| 0.044 | 0.016 | 0.044 | Integrin alpha2 antagonist | |||
| 0.04 | 0.012 | 0.04 | Uridine phosphorylase inhibitor | 0.03 0.017 CID_18763384 | ||
| 0.167 | 0.139 | 0.167 | ErbB-1 antagonist | |||
| 0.065 | 0.038 | 0.065 | NMDA 2C receptor antagonist | |||
| 0.051 | 0.024 | 0.051 | Benzodiazepine inverse agonist | |||
| 0.036 | 0.009 | 0.036 | Follicle-stimulating hormone agonist | |||
| 0.065 | 0.037 | 0.065 | Histone deacetylase SIRT3 inhibitor | 0.058 0.057 CID_18763384 | ||
| 0.052 | 0.025 | 0.052 | Thymidylate synthase inhibitor | 0.048 0.031 CID_18763384 | ||
| 0.128 | 0.101 | 0.128 | NOS3 expression enhancer | |||
| 0.095 | 0.069 | 0.095 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.04 | 0.014 | 0.04 | Liver X receptor antagonist | |||
| 0.04 | 0.015 | 0.04 | Melatonin 1 agonist | 0.034 0.021 CID_18763384 | ||
| 0.054 | 0.029 | 0.054 | Phosphodiesterase 2A inhibitor | |||
| 0.106 | 0.081 | 0.106 | TRKA antagonist | |||
| 0.045 | 0.02 | 0.045 | TRPM8 blocker | |||
| 0.036 | 0.011 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.03 0.018 CID_18763384 | ||
| 0.089 | 0.064 | 0.089 | Glutamate release inhibitor | |||
| 0.034 | 0.01 | 0.034 | Somatostatin 4 antagonist | 0.029 0.012 CID_18763384 | ||
| 0.081 | 0.057 | 0.081 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.188 | 0.165 | 0.188 | 12-Lipoxygenase inhibitor | |||
| 0.045 | 0.022 | 0.045 | Melanocortin 1 antagonist | 0.04 0.025 CID_18763384 | ||
| 0.06 | 0.036 | 0.06 | Beta 1 adrenoreceptor antagonist | |||
| 0.028 | 0.005 | 0.028 | Somatostatin 2 agonist | 0.014 0.01 CID_18763384 | ||
| 0.058 | 0.035 | 0.058 | Cyclin B inhibitor | |||
| 0.064 | 0.041 | 0.064 | I kappa B kinase 2 inhibitor | |||
| 0.048 | 0.026 | 0.048 | NMDA receptor subunit 3B antagonist | |||
| 0.093 | 0.071 | 0.093 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.066 | 0.044 | 0.066 | Dopamine D1 antagonist | 0.064 0.046 CID_18763384 | ||
| 0.054 | 0.032 | 0.054 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.028 | 0.006 | 0.028 | Cholecystokinin A agonist | |||
| 0.032 | 0.01 | 0.032 | Thymidine phosphorylase inhibitor | 0.027 0.017 CID_18763384 | ||
| 0.057 | 0.035 | 0.057 | Dihydroorotate oxidase inhibitor | |||
| 0.029 | 0.008 | 0.029 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.061 | 0.04 | 0.061 | Acetylcholine M5 receptor antagonist | 0.055 0.05 CID_18763384 | ||
| 0.072 | 0.051 | 0.072 | Orexin receptor 1 antagonist | |||
| 0.135 | 0.115 | 0.135 | TRKC antagonist | |||
| 0.032 | 0.012 | 0.032 | Dopamine autoreceptor agonist | 0.022 0.018 CID_18763384 | ||
| 0.075 | 0.055 | 0.075 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.026 | 0.006 | 0.026 | Alpha 2a adrenoreceptor agonist | |||
| 0.081 | 0.061 | 0.081 | MAP-kinase-activated kinase inhibitor | |||
| 0.036 | 0.017 | 0.036 | Protein kinase C beta I inhibitor | 0.033 0.025 CID_18763384 | ||
| 0.223 | 0.204 | 0.223 | Alpha-glucosidase inhibitor | |||
| 0.068 | 0.049 | 0.068 | Exportin-1 inhibitor | 0.064 0.058 CID_18763384 | ||
| 0.121 | 0.102 | 0.121 | Farnesoid X receptor antagonist | |||
| 0.066 | 0.048 | 0.066 | Acetylcholine M5 receptor agonist | |||
| 0.063 | 0.046 | 0.063 | Glucagon-like peptide 1 agonist | |||
| 0.092 | 0.075 | 0.102 | Anabolic | 0.093 0.073 CID_18427220 0.102 0.06 CID_18763384 | CID_18763384 | |
| 0.039 | 0.023 | 0.065 | Kainate receptor 2 antagonist | 0.065 0.01 CID_18763384 | CID_18763384 | |
| 0.042 | 0.025 | 0.042 | Dopamine D5 agonist | 0.038 0.031 CID_18763384 | ||
| 0.19 | 0.174 | 0.244 | Cholesterol antagonist | 0.244 0.129 CID_18427220 | CID_18427220 | |
| 0.076 | 0.06 | 0.076 | Platelet growth factor antagonist | |||
| 0.026 | 0.011 | 0.026 | Bombesin agonist | |||
| 0.061 | 0.046 | 0.061 | NMDA receptor agonist | |||
| 0.032 | 0.017 | 0.032 | Cyclin E2 inhibitor | |||
| 0.044 | 0.029 | 0.044 | Dihydrofolate reductase inhibitor | |||
| 0.057 | 0.043 | 0.073 | Aromatase inhibitor | 0.073 0.032 CID_18763384 | CID_18763384 | |
| 0.048 | 0.034 | 0.05 | Dopamine beta hydroxylase inhibitor | 0.05 0.031 CID_18763384 | CID_18763384 | |
| 0.125 | 0.111 | 0.128 | Hexokinase inhibitor | 0.128 0.106 CID_18763384 | CID_18763384 | |
| 0.05 | 0.036 | 0.05 | Potassium channel (Inward rectifier) activator | |||
| 0.052 | 0.038 | 0.052 | Histamine agonist | |||
| 0.086 | 0.072 | 0.087 | Protein kinase C mu inhibitor | 0.087 0.071 CID_18427220 | CID_18427220 | |
| 0.017 | 0.004 | 0.022 | Progesterone receptor A antagonist | 0.022 0.003 CID_18763384 | CID_18763384 | |
| 0.071 | 0.057 | 0.071 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.046 | 0.033 | 0.046 | Endothelin-converting enzyme inhibitor | |||
| 0.022 | 0.009 | 0.072 | Progesterone receptor B antagonist | 0.072 0.002 CID_18763384 | CID_18763384 | |
| 0.121 | 0.107 | 0.121 | Acetylcholine M1 receptor antagonist | |||
| 0.04 | 0.026 | 0.04 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.068 | 0.055 | 0.068 | Cathepsin G inhibitor | |||
| 0.025 | 0.012 | 0.025 | ICAM 1 antagonist | |||
| 0.048 | 0.035 | 0.048 | Topoisomerase II beta inhibitor | |||
| 0.058 | 0.045 | 0.058 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.021 | 0.009 | 0.021 | Alpha 2b adrenoreceptor agonist | |||
| 0.098 | 0.085 | 0.098 | Aurora-B kinase inhibitor | |||
| 0.053 | 0.041 | 0.053 | Glucosylceramidase inhibitor | |||
| 0.08 | 0.068 | 0.08 | Estrogen-related receptor beta agonist | |||
| 0.047 | 0.035 | 0.047 | Potassium channel (ATP-sensitive) activator | |||
| 0.021 | 0.009 | 0.021 | Alpha 2c adrenoreceptor agonist | |||
| 0.09 | 0.078 | 0.09 | Insulin receptor antagonist | |||
| 0.079 | 0.067 | 0.079 | NMDA receptor antagonist | |||
| 0.047 | 0.036 | 0.047 | Histamine H4 receptor antagonist | |||
| 0.016 | 0.005 | 0.016 | Cyclin D2 inhibitor | |||
| 0.039 | 0.028 | 0.048 | AMPA 4 receptor antagonist | 0.048 0.017 CID_18763384 | CID_18763384 | |
| 0.025 | 0.013 | 0.025 | Dopamine D1 agonist | |||
| 0.033 | 0.022 | 0.033 | Melatonin agonist | |||
| 0.034 | 0.023 | 0.034 | Glutamate (mGluR4) agonist | |||
| 0.043 | 0.033 | 0.043 | Dihydroorotase inhibitor | |||
| 0.038 | 0.027 | 0.038 | NMDA receptor subunit 3A antagonist | |||
| 0.14 | 0.129 | 0.156 | Phospholipase C inhibitor | 0.156 0.094 CID_18427220 | CID_18427220 | |
| 0.042 | 0.032 | 0.042 | Nerve growth factor antagonist | |||
| 0.067 | 0.057 | 0.067 | Aminopeptidase I inhibitor | |||
| 0.048 | 0.039 | 0.048 | Beta 2 adrenoreceptor antagonist | |||
| 0.014 | 0.005 | 0.014 | Imidazoline I2 receptor antagonist | |||
| 0.026 | 0.017 | 0.026 | Acid ceramidase inhibitor | |||
| 0.02 | 0.011 | 0.02 | Bombesin 3 receptor agonist | |||
| 0.046 | 0.037 | 0.046 | Phosphodiesterase 4A inhibitor | |||
| 0.063 | 0.054 | 0.063 | Check point kinase 1 inhibitor | |||
| 0.075 | 0.066 | 0.075 | MAP kinase 7 inhibitor | |||
| 0.027 | 0.018 | 0.027 | Urotensin II agonist | |||
| 0.044 | 0.035 | 0.044 | Purinergic P2X4 antagonist | |||
| 0.043 | 0.034 | 0.043 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.027 | 0.018 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 CID_18427220 | ||
| 0.04 | 0.032 | 0.04 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.061 | 0.053 | 0.061 | Beta adrenoreceptor antagonist | |||
| 0.044 | 0.036 | 0.044 | Melanocortin antagonist | 0.042 0.04 CID_18763384 | ||
| 0.021 | 0.013 | 0.021 | Histone-lysine N-methyltransferase EZH2 inhibitor | |||
| 0.055 | 0.047 | 0.055 | Botulinum neurotoxin type A inhibitor | |||
| 0.04 | 0.033 | 0.04 | Guanylate cyclase inhibitor | |||
| 0.194 | 0.187 | 0.194 | Apoptosis antagonist | |||
| 0.115 | 0.107 | 0.135 | Cell wall synthesis inhibitor | 0.135 0.08 CID_18763384 | CID_18763384 | |
| 0.041 | 0.033 | 0.041 | Glutamate (mGluR group III) agonist | |||
| 0.057 | 0.049 | 0.068 | Ryanodine receptor antagonist | 0.068 0.02 CID_18763384 | CID_18763384 | |
| 0.062 | 0.054 | 0.062 | Orexin receptor antagonist | |||
| 0.039 | 0.031 | 0.039 | Thymidine kinase inhibitor | |||
| 0.039 | 0.032 | 0.039 | Melanocortin 4 antagonist | |||
| 0.086 | 0.079 | 0.086 | Xanthine oxidase inhibitor | 0.084 0.082 CID_18763384 | ||
| 0.111 | 0.103 | 0.13 | Protein kinase stimulant | 0.11 0.105 CID_18427220 0.13 0.083 CID_18763384 | CID_18763384 | |
| 0.146 | 0.139 | 0.146 | Insulin sensitizer | |||
| 0.066 | 0.059 | 0.066 | MAP kinase 11 inhibitor | |||
| 0.059 | 0.052 | 0.059 | CDC25B inhibitor | |||
| 0.03 | 0.023 | 0.03 | Potassium channel small-conductance Ca-activated activator | |||
| 0.057 | 0.051 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.018 | 0.012 | 0.018 | Cyclin T1 inhibitor | |||
| 0.067 | 0.061 | 0.067 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.025 | 0.02 | 0.025 | Integrin alpha2beta1 antagonist | |||
| 0.09 | 0.085 | 0.09 | Hedgehog signaling inhibitor | |||
| 0.05 | 0.045 | 0.05 | Carbonic anhydrase VB inhibitor | |||
| 0.01 | 0.005 | 0.01 | Thyroid hormone beta agonist | |||
| 0.089 | 0.084 | 0.089 | Cyclin-dependent kinase 2 inhibitor | |||
| 0.078 | 0.073 | 0.078 | Alpha adrenoreceptor antagonist | |||
| 0.02 | 0.016 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.107 | 0.102 | 0.107 | Protein kinase (CK1) inhibitor | |||
| 0.066 | 0.062 | 0.066 | Alpha 1 adrenoreceptor antagonist | |||
| 0.038 | 0.033 | 0.038 | Liver X receptor alpha agonist | |||
| 0.084 | 0.08 | 0.084 | Potassium channel (Voltage-sensitive) activator | |||
| 0.044 | 0.04 | 0.044 | Transforming growth factor beta 1 antagonist | |||
| 0.016 | 0.012 | 0.016 | Nicotinic alpha4 receptor agonist | 0.015 0.014 CID_18763384 | ||
| 0.107 | 0.103 | 0.107 | DNA repair enzyme inhibitor | |||
| 0.055 | 0.051 | 0.069 | Purinergic P2X1 antagonist | 0.069 0.033 CID_18427220 | CID_18427220 | |
| 0.024 | 0.021 | 0.024 | Complement factor 1s inhibitor | |||
| 0.023 | 0.02 | 0.023 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.07 | 0.066 | 0.07 | Vanilloid 4 agonist | |||
| 0.012 | 0.008 | 0.012 | Melatonin 2 antagonist | 0.012 0.009 CID_18763384 | ||
| 0.021 | 0.017 | 0.021 | Glutamate (mGluR1a) agonist | |||
| 0.015 | 0.012 | 0.015 | CC chemokine 10 receptor antagonist | |||
| 0.114 | 0.112 | 0.114 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.066 | 0.064 | 0.079 | Na+ K+ transporting ATPase inhibitor | 0.079 0.052 CID_18763384 | CID_18763384 | |
| 0.042 | 0.04 | 0.042 | AMPA receptor antagonist | |||
| 0.066 | 0.063 | 0.075 | Glutamate dehydrogenase inhibitor | 0.075 0.05 CID_18427220 | CID_18427220 | |
| 0.046 | 0.044 | 0.046 | mTOR inhibitor | |||
| 0.082 | 0.08 | 0.082 | Polo-like kinase-1 inhibitor | |||
| 0.039 | 0.037 | 0.039 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.018 | 0.016 | 0.018 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.102 | 0.1 | 0.102 | Cyclooxygenase 3 inhibitor | |||
| 0.035 | 0.033 | 0.035 | Substance P antagonist | |||
| 0.007 | 0.005 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.089 | 0.087 | 0.122 | DNA intercalator | 0.122 0.056 CID_18427220 | CID_18427220 | |
| 0.097 | 0.095 | 0.097 | Protein kinase (CK1) delta inhibitor | |||
| 0.024 | 0.023 | 0.024 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.053 | 0.052 | 0.053 | Dopamine D3 antagonist | |||
| 0.026 | 0.025 | 0.026 | Glucosylceramidase stimulant | |||
| 0.137 | 0.136 | 0.137 | Non-steroidal antiinflammatory agent | |||
| 0.036 | 0.035 | 0.036 | CDK5/p25 inhibitor | |||
| 0.105 | 0.104 | 0.105 | Sodium channel (voltage-gated) blocker | |||
| 0.05 | 0.055 | 0.07 | Carbamoyl phosphate synthetase inhibitor | 0.07 0.035 CID_18427220 | CID_18427220 | |
| 0.032 | 0.038 | 0.042 | Kainate receptor antagonist | 0.042 0.027 CID_18763384 | CID_18763384 | |
| 0.022 | 0.028 | 0.029 | AMPA 3 receptor antagonist | 0.029 0.021 CID_18763384 | CID_18763384 | |
| 0.033 | 0.04 | 0.043 | Glutamate (mGluR8) agonist | 0.043 0.018 CID_18763384 | CID_18763384 | |
| 0.051 | 0.067 | 0.077 | Phosphofructokinase-1 inhibitor | 0.077 0.043 CID_18427220 | CID_18427220 | |
| 0.023 | 0.044 | 0.034 | Methionyl aminopeptidase 1 inhibitor | 0.034 0.019 CID_18763384 | CID_18763384 | |
| 0.181 | 0.203 | 0.2 | Antithrombotic | 0.2 0.178 CID_18763384 | CID_18763384 | |
| 0.038 | 0.062 | 0.065 | Acyl-CoA dehydrogenase inhibitor | 0.049 0.044 CID_18427220 0.065 0.029 CID_18763384 | CID_18763384 | |
| 0.058 | 0.083 | 0.067 | CDC25A inhibitor | 0.067 0.061 CID_18763384 | CID_18763384 | |
| 0.058 | 0.085 | 0.084 | Adenosine A3 receptor antagonist | 0.084 0.038 CID_18427220 | CID_18427220 | |
| 0.138 | 0.166 | 0.158 | Immunostimulant | 0.158 0.148 CID_18763384 | CID_18763384 | |
| 0.163 | 0.191 | 0.2 | Transcription factor STAT3 inhibitor | 0.2 0.133 CID_18763384 | CID_18763384 | |
| 0.165 | 0.201 | 0.199 | Transcription factor STAT inhibitor | 0.199 0.14 CID_18763384 | CID_18763384 | |
| 0.215 | 0.254 | 0.451 | Apoptosis agonist | 0.451 0.091 CID_18763384 | CID_18763384 | |
| 0.006 | 0.058 | 0.03 | Progesterone agonist | 0.03 0.007 CID_18427220 | CID_18427220 | |
| 0.034 | 0.089 | 0.05 | Lysine-specific demethylase 1A inhibitor | 0.05 0.046 CID_18763384 | CID_18763384 | |
| 0.012 | 0.077 | 0.048 | CYP24 inhibitor | 0.048 0.005 CID_18763384 | CID_18763384 | |
| 0.073 | 0.142 | 0.123 | Tubulin antagonist | 0.123 0.077 CID_18763384 | CID_18763384 | |
| 0.062 | 0.143 | 0.104 | Thioredoxin inhibitor | 0.104 0.044 CID_18763384 | CID_18763384 | |
| 0.118 | 0.208 | 0.182 | Catenin beta inhibitor | 0.182 0.05 CID_18763384 | CID_18763384 | |
| 0.031 | 0.124 | 0.167 | HIV-1 reverse transcriptase inhibitor | 0.167 0.012 CID_18427220 | CID_18427220 | |
| 0.084 | 0.179 | 0.173 | Angiogenesis stimulant | 0.173 0.109 CID_18763384 | CID_18763384 | |
| 0.065 | 0.161 | 0.086 | T cell inhibitor | 0.086 0.047 CID_18763384 | CID_18763384 | |
| 0.032 | 0.137 | 0.078 | Antiviral (Hepatitis D) | 0.078 0.009 CID_18763384 | CID_18763384 | |
| 0.011 | 0.135 | 0.8 | Opioid delta receptor agonist | 0.8 0.002 CID_18427220 | CID_18427220 | |
| 0.029 | 0.158 | 0.078 | Parathyroid hormone antagonist | 0.078 0.005 CID_18763384 | CID_18763384 | |
| 0.014 | 0.144 | 0.307 | Opioid mu receptor agonist | 0.307 0.004 CID_18427220 | CID_18427220 | |
| 0.013 | 0.158 | 0.045 | Vitamin D receptor antagonist | 0.045 0.005 CID_18763384 | CID_18763384 | |
| 0.15 | 0.312 | 0.476 | Analgesic | 0.476 0.056 CID_18427220 | CID_18427220 | |
| 0.035 | 0.2 | 0.149 | Topoisomerase I inhibitor | 0.149 0.041 CID_18427220 | CID_18427220 | |
| 0.068 | 0.273 | 0.148 | Antimitotic | 0.148 0.123 CID_18763384 | CID_18763384 | |
| 0.127 | 0.347 | 0.226 | Caspase 3 stimulant | 0.226 0.136 CID_18763384 | CID_18763384 | |
| 0.019 | 0.283 | 0.055 | Acetyl-CoA transferase 2 inhibitor | 0.055 0.043 CID_18427220 | CID_18427220 | |
| 0.009 | 0.305 | 0.66 | Opioid agonist | 0.66 0.003 CID_18427220 | CID_18427220 | |
| 0.017 | 0.356 | 0.408 | Analgesic, opioid | 0.408 0.005 CID_18427220 | CID_18427220 | |
| 0.043 | 0.444 | 0.212 | Vasodilator | 0.212 0.096 CID_18427220 | CID_18427220 | |
| 0.041 | 0.442 | 0.18 | Nitric oxide antagonist | 0.18 0.077 CID_18763384 | CID_18763384 | |
| 0.082 | 0.58 | 0.252 | Peptidyltransferase inhibitor | 0.252 0.049 CID_18427220 | CID_18427220 | |
| 0.026 | 0.528 | 0.163 | DNA polymerase I inhibitor | 0.163 0.042 CID_18427220 | CID_18427220 | |
| 0.004 | 0.766 | 0.576 | Opioid kappa receptor agonist | 0.576 0.002 CID_18427220 | CID_18427220 | |
| 0.002 | 0.887 | 0.026 | Adenosine A1 receptor agonist | 0.026 0.014 CID_18427220 | CID_18427220 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |